Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

NCT01150617 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Stopped end-point reached

Conditions

Type 2 Diabetes Mellitus
Peripheral Vascular Disease

Interventions

DRUG: Insulin glargine plus insulin analogues

Sponsor

IRCCS San Raffaele